Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer
Biomacromolecules · 2025
DOI: 10.1021/acs.biomac.5c00186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Danjun Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Doxorubicin, Micelles, Photothermal Therapy, Tumor Hypoxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Nanomedicines with a size of approximately 200 nm preferentially accumulate at the tumor peripheries but exhibit limited penetration into deeper hypoxic regions. To overcome this, we engineered near-infrared (NIR) light-triggered, size-tunable nanomicelles (Au@PtNRs/DOX-M) to enhance tumor accumulation and penetration, while alleviating hypoxia. Dumbbell-shaped platinum-deposited gold nanorods (Au@PtNRs), with a high photothermal conversion efficiency (68.44%), were integrated into thermoresponsive, doxorubicin (DOX)-loaded nanomicelles. Upon NIR irradiation, Au@PtNRs induced light-to-heat conversion, disassembling micelles into ultrasmall micelles for enhanced tumor penetration and on-demand DOX release. Concurrently, Pt nanoparticles catalyzed the decomposition of reactive oxygen species (ROS) to mitigate ROS-induced damage to adjacent healthy cells, and scavenged the elevated H 2 O 2 within tumors, generating abundant oxygen to reoxygenate the hypoxic microenvironment. This study establishes an efficient, size-tunable nanomicelle platform for enhancing hypoxia-impeded deep penetration of nanomedicines and offers a promising strategy for synergistic chemo-photothermal therapy, achieving tumor inhibition rates of up to 99% in MCF-7 tumor-bearing mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
- Hangzhou Guoguang Pharmaceutical Co, Ltd, Hangzhou 310018, China.
ORCID-Profile: Danjun Wu, Gensheng Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Wu, D., Ji, Y., Ji, W., Tian, H., Dai, Y., Chen, Y., Shen, G., & Yang, G. (2025). Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00186
Vancouver
Wu D, Ji Y, Ji W, Tian H, Dai Y, Chen Y, et al. Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00186
BibTeX
@article{Wu2025,
author = {Wu, Danjun and Ji, Yaning and Ji, Weili and Tian, Hong and Dai, Yiwei and Chen, Yifei and Shen, Gongmin and Yang, Gensheng},
title = {Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer},
journal = {Biomacromolecules},
year = {2025},
doi = {10.1021/acs.biomac.5c00186}
}
EUVIMED